- Imaging Scientist, Lawson Health Research Institute
- Associate Professor, Department of Medical Biophysics and Department of Medical Imaging, University of Western Ontario
Neil Gelman received his Ph.D. in Physics at the University of Toronto in 1994. His Ph.D. work involved 19F solid-state NMR studies of bone mineral aimed at quantifying bone fluorine levels in osteoporosis patients receiving fluoride-based treatment. Neil then took up a post-doc within the Department of Medical Biophysics at the University of Toronto. His research involved furthering the development of a new method of spatial encoding in MRI. Neil then moved on to Henry Ford Hospital in Detroit where he worked on MRI methods to assess brain iron levels in patients with Parkinson's disease. In July 2000, Neil began research involving neonatal MRI at LHRI. This work led to the first Canadian research program involving brain MRI applied to new-born infants who are at risk for neurodevelopmental disorders. Internationally, this was the first program to deal with the challenges of performing neonatal MRI research at 3 Tesla. Neil and his collaborators have devoted much effort to be able to image infants without the use of sedation and without high acoustic noise level exposure. Most recently, Neil has also become interested in the application of MRI for diagnosis and treatment monitoring in breast cancer. Neil holds a joint appointment in the Departments of Medical Biophysics and Medical Imaging at UWO, and is a scientist in the imaging group at LHRI.
Development and application of MRI methods for:
1) Assessing brain injury and impaired brain development in new born infants
2) Improving diagnosis and monitoring therapy for breast cancer